These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder. De La Garza R; Verrico CD; Newton TF; Mahoney JJ; Thompson-Lake DG Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv098. PubMed ID: 26364275 [TBL] [Abstract][Full Text] [Related]
4. Negative cocaine effect expectancies are associated with subjective response to cocaine challenge in recreational cocaine users. Lundahl LH; Lukas SE Addict Behav; 2007 Jun; 32(6):1262-71. PubMed ID: 17110052 [TBL] [Abstract][Full Text] [Related]
5. Insights from Preclinical Choice Models on Treating Drug Addiction. Banks ML; Negus SS Trends Pharmacol Sci; 2017 Feb; 38(2):181-194. PubMed ID: 27916279 [TBL] [Abstract][Full Text] [Related]
6. Acute drug effects differentially predict desire to take dextroamphetamine again for work and recreation. Hoots JK; Webber HE; Nunez C; Cooper JA; Lopez-Gamundi P; Lawlor VM; Lane SD; Treadway MT; Wardle MC Psychopharmacology (Berl); 2021 Oct; 238(10):2815-2826. PubMed ID: 34137904 [TBL] [Abstract][Full Text] [Related]
7. Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers. Carter LP; Kleykamp BA; Griffiths RR; Mintzer MZ Psychopharmacology (Berl); 2013 Mar; 226(1):53-63. PubMed ID: 23096769 [TBL] [Abstract][Full Text] [Related]
8. Levels of neural progenitors in the hippocampus predict memory impairment and relapse to drug seeking as a function of excessive methamphetamine self-administration. Recinto P; Samant AR; Chavez G; Kim A; Yuan CJ; Soleiman M; Grant Y; Edwards S; Wee S; Koob GF; George O; Mandyam CD Neuropsychopharmacology; 2012 Apr; 37(5):1275-87. PubMed ID: 22205547 [TBL] [Abstract][Full Text] [Related]
9. A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans. Kirkpatrick MG; Gunderson EW; Perez AY; Haney M; Foltin RW; Hart CL Psychopharmacology (Berl); 2012 Jan; 219(1):109-22. PubMed ID: 21713605 [TBL] [Abstract][Full Text] [Related]
10. Reinforcing effects of d-amphetamine: influence of novel ratios on a progressive-ratio schedule. Sevak RJ; Stoops WW; Glaser PE; Hays LR; Rush CR Behav Pharmacol; 2010 Dec; 21(8):745-53. PubMed ID: 20944503 [TBL] [Abstract][Full Text] [Related]